| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-15043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0668
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate |
2021-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2023-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2023-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114507694-B |
| titleOfInvention |
Preparation method and application of induced insulin-secreting stem cells |
| abstract |
The invention discloses a preparation method and application of stem cells with induced insulin secretion. At present, recombinant insulin is mainly used clinically to treat insulin-dependent diabetes. Mesenchymal stem cells are a kind of pluripotent stem cells, which have all the common characteristics of stem cells, that is, self-renewal and multi-directional differentiation capabilities, and have strong immune regulation functions, and have a therapeutic effect on the reduction of islet function caused by autoimmune damage. . Inducible insulin-secreting umbilical cord mesenchymal stem cells that can respond to changes in glucose concentration have broad application prospects in the treatment of diabetes. |
| priorityDate |
2021-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |